Page last updated: 2024-11-03

resorcinol and Abnormalities, Drug-Induced

resorcinol has been researched along with Abnormalities, Drug-Induced in 2 studies

resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research Excerpts

ExcerptRelevanceReference
"Resorcinol's potency to inhibit TPO was profoundly lower than that of PTU or MMI."2.53A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats. ( Motonaga, K; Odawara, K; Ota, M; Saito, S; Welsch, F, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Motonaga, K1
Ota, M1
Odawara, K1
Saito, S1
Welsch, F1
BUCHANAN, WW1
HARDEN, RM1
CLARK, DH1

Reviews

1 review available for resorcinol and Abnormalities, Drug-Induced

ArticleYear
A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
    Regulatory toxicology and pharmacology : RTP, 2016, Volume: 80

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Autoantigens; Biomarkers; Dose-Response

2016

Other Studies

1 other study available for resorcinol and Abnormalities, Drug-Induced

ArticleYear
HASHIMOTO'S THYROIDITIS: ITS DIFFERENTIATION FROM SIMPLE GOITRE, THYROID NEOPLASM DRUG-INDUCED GOITRE, AND DYSHORMONOGENESIS.
    The British journal of surgery, 1965, Volume: 52

    Topics: Abnormalities, Drug-Induced; Antithyroid Agents; Blood Chemical Analysis; Blood Sedimentation; Diagn

1965